Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Radiology|January 10, 2022
Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chronic kidney diseaseEnsar Yekeler, Ganesh Krishnamurthy, Christopher L Smith, et al.
European Journal of Human Genetics : EJHG|May 23, 2022
Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomalyMandi Liu, Christopher L Smith, David M Biko, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 18, 2021
Dynamic Contrast Magnetic Resonance Lymphangiography Localizes Lymphatic Leak to the Duodenum in Protein-Losing EnteropathyJefferson N Brownell, David M Biko, Petar Mamula, et al.
Pediatric Pulmonology|September 13, 2018
Bronchoscopic and histologic findings during lymphatic intervention for plastic bronchitisAlexandra T Geanacopoulos, Jill J Savla, Jennifer Pogoriler, et al.
World Journal for Pediatric & Congenital Heart Surgery|December 15, 2019
Protein Losing Enteropathy After Fontan Operation: Glimpses of Clarity Through the Lifting FogJack Rychik, Kathryn M Dodds, David Goldberg, et al.
Pediatric Cardiology|November 29, 2021
Post-operative Chylothorax in Patients with Repaired Transposition of the Great ArteriesDanish Vaiyani, Madhumitha Saravanan, Yoav Dori, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 4, 2020
Neonatal lymphatic flow disorders: impact of lymphatic imaging and interventions on outcomesErin Pinto, Yoav Dori, Christopher Smith, et al.
Journal of the American Heart Association|September 27, 2021
Intrahepatic Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography: Potential Imaging Signature for Protein-Losing Enteropathy in Congenital Heart DiseaseBethan A Lemley, Dave M Biko, Aaron G Dewitt, et al.
Circulation. Cardiovascular Interventions|September 4, 2025
Percutaneous Thoracic Duct Externalization and Autotransfusion in Patients With Lymphatic Failure Due to Elevated Central Venous PressureYoav Dori, Erin Pinto, Lauren Biroc, et al.
Nature Medicine|July 3, 2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Michael E March, Alvaro Gutierrez-Uzquiza, et al.
Pageof 3